Adjustments for Stock Splits Clause Example from Business Contracts

This example Adjustments for Stock Splits clause appears in 15 contracts from 15 companies

Adjustments for Stock Splits. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any stock split, stock dividend or similar event effected with respect to the Placement Shares.
Found in ARQULE INC contract
ARQULE INC Contracts

ArQule, Inc. Common Stock ($0.01 par value per share) Capital on Demand™ SalesAgreement (Filed With SEC on October 26, 2016)

Onconova Therapeutics, Inc. Contracts

ONCONOVA THERAPEUTICS, INC. Shares of Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement (Filed With SEC on December 5, 2016)

Cyclacel Pharmaceuticals, Inc. Contracts

Cyclacel Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on June 23, 2016)

ARCA biopharma, Inc. Contracts

ARCA biopharma, Inc. Common Stock ($0.001 par value pershare) Capital on Demand Sales Agreement (Filed With SEC on January 11, 2017)

OCULAR THERAPEUTIX, INC Contracts

OCULAR THERAPEUTIX, INC. Shares of Common Stock (par value$0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 30, 2016)

Ampio Pharmaceuticals, Inc. Contracts

AMPIO PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on February 10, 2016)

HEAT BIOLOGICS, INC. Contracts

At Market Issuance Sales Agreement, dated August 15, 2016, by and between Heat Biologics, Inc. and FBR Capital Markets & Co (Filed With SEC on August 15, 2016)

ACELRX PHARMACEUTICALS INC Contracts

AcelRx Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on June 21, 2016)

Fluent, Inc. Contracts

IDI, INC. Common Stock ($0.0005 parvalue per share) Capital on Demand Sales Agreement (Filed With SEC on January 15, 2016)

Corbus Pharmaceuticals Holdings, Inc. Contracts

CORBUS PHARMACEUTICALS HOLDINGS, INC. Shares of Common Stock (par value$0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 23, 2016)

Synthetic Biologics, Inc. Contracts

SYNTHETIC BIOLOGICS, INC. Shares of Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on August 5, 2016)

TITAN PHARMACEUTICALS INC Contracts

TITAN PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on September 1, 2016)

Celldex Therapeutics, Inc. Contracts

CELLDEX THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on May 19, 2016)

TRANSENTERIX INC. Contracts

TransEnterix, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSMSales Agreement (Filed With SEC on February 9, 2016)

Stereotaxis, Inc. Contracts

STEREOTAXIS, INC. $18,000,000 of Shares of CommonStock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on May 16, 2014)